TAF5L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.360200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.123200E-01
Normal-vs-Stage2
7.090800E-01
Normal-vs-Stage3
4.705400E-01
Normal-vs-Stage4
8.717600E-02
Stage1-vs-Stage2
5.653600E-01
Stage1-vs-Stage3
1.240210E-01
Stage1-vs-Stage4
2.399000E-01
Stage2-vs-Stage3
1.501020E-01
Stage2-vs-Stage4
9.041500E-02
Stage3-vs-Stage4
4.090200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.835600E-01
Normal-vs-AfricanAmerican
3.754000E-02
Normal-vs-Asian
8.252600E-01
Caucasian-vs-AfricanAmerican
5.151900E-02
Caucasian-vs-Asian
9.781000E-01
AfricanAmerican-vs-Asian
1.078220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.694800E-01
Normal-vs-Female
6.833600E-01
Male-vs-Female
8.962800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.116400E-01
Normal-vs-Age(41-60Yrs)
5.053000E-01
Normal-vs-Age(61-80Yrs)
8.391000E-01
Normal-vs-Age(81-100Yrs)
6.306400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.800800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.992200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.605600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.908820E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.316000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.306600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.930000E-01
Normal-vs-Daily Drinker
8.195600E-01
Normal-vs-Weekly Drinker
6.648600E-01
Normal-vs-Occasional Drinker
4.578400E-01
Normal-vs-Social Drinker
6.146600E-01
Non Drinker-vs-Daily Drinker
4.319400E-01
Non Drinker-vs-Weekly Drinker
4.474600E-01
Non Drinker-vs-Occasional Drinker
2.216000E-01
Non Drinker-vs-Social Drinker
6.180200E-01
Daily Drinker-vs-Weekly Drinker
2.562200E-01
Daily Drinker-vs-Occasional Drinker
8.362000E-02
Daily Drinker-vs-Social Drinker
2.560800E-01
Weekly Drinker-vs-Occasional Drinker
9.271600E-01
Weekly Drinker-vs-Social Drinker
6.166200E-01
Occasional Drinker-vs-Social Drinker
4.662800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.063800E-02
Normal-vs-Grade 2
4.899900E-03
Normal-vs-Grade 3
2.012400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.398400E-01
Grade 1-vs-Grade 3
1.288830E-01
Grade 1-vs-Grade 4
9.063800E-02
Grade 2-vs-Grade 3
7.646000E-01
Grade 2-vs-Grade 4
4.899900E-03
Grade 3-vs-Grade 4
2.012400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.564400E-01
Normal-vs-NonDiabetic
7.364600E-01
Diabetic-vs-NonDiabetic
3.358400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.132600E-01
Normal-vs-NoPancreatitis
8.271400E-01
Pancreatitis-vs-NoPancreatitis
6.625000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.449800E-01
Normal-vs-N1
7.440200E-01
N0-vs-N1
7.052400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.713400E-01
Normal-vs-TP53-NonMutant
6.677800E-01
TP53-Mutant-vs-TP53-NonMutant
7.893200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
